期刊文献+

胺碘酮联合阿司匹林治疗心房颤动的疗效观察 被引量:1

Curative effect of Amiodarone combined with Aspirin in the treatment of atrial fibrillation
下载PDF
导出
摘要 目的:评价胺碘酮联合阿司匹林治疗心房颤动(房颤)的疗效。方法:将57例房颤患者随机分为胺碘酮+阿司匹林组(Ⅰ组,n=28)、洋地黄+阿司匹林组(Ⅱ组,n=29),治疗及随访时间6个月,观察治疗过程中房颤的复发、心律维持及血栓栓塞发生情况。结果:房颤复发Ⅰ组3例(10.7%),Ⅱ组8例(27.6%),Ⅰ组低于Ⅱ组(P<0.05);心室率控制Ⅰ组25例(89.3%),Ⅱ组15例(51.7%),Ⅰ组优于Ⅱ组(P<0.05);血栓栓塞Ⅰ组2例(7.1%),Ⅱ组3例(10.3%),两组差异无统计学意义(P>0.05)。结论:对心功能正常者,胺碘酮联合阿司匹林降低房颤复发及控制心室率方面优于洋地黄联用阿司匹林,但在预防血栓栓塞症的发生方面无明显差异。就目前来看,胺碘酮联用阿司匹林仍是治疗房颤最佳选择。 Objective:To evaluate the effect of Amiodarone combined with Aspirin in the treatment of atrial fibrillation.Methods:57 patients with atrial fibrillation were randomly divided into amiodarone+aspirin group(group Ⅰ,n=28)and Digitalis+aspirin group(group Ⅱ,n=29),treatment and follow up of 6 months.Observed in the course of treatment of atrial fibrillation recurrence,rhythm maintenance and thromboembolism occurs.Results:3 cases of atrial fibrillation recurrence in group Ⅰ,8 cases of atrial fibrillation recurrence in group Ⅱ,group Ⅰ was lower than group Ⅱ(P〈0.05);25 cases of ventricular rate control in group Ⅰ,15 cases of ventricular rate control in group Ⅱ,group Ⅰ was better than Group Ⅱ(P〈0.05);2 cases of thromboembolism in group Ⅰ,3 cases of thromboembolism in group Ⅱ,there was no statistical difference(P〉0.05).Conclusion:For patients with normal cardiac function,Amiodarone combined with Aspirin is better than Digitalis combined with Aspirin on reducing the recurrence of atrial fibrillation and ventricular rate control,but there is no significant difference in the prevention of thromboembolism occurrence.At present,Amiodarone combined with Aspirin is still the best choice.
作者 黄建军
机构地区 成都北新医院
出处 《中国民康医学》 2012年第16期1925-1926,1930,共3页 Medical Journal of Chinese People’s Health
关键词 心房颤动 阿司匹林 胺碘酮 Atrial fibrillation; Aspirin; Amiodarone
  • 相关文献

参考文献5

  • 1黄从新.心房颤动[J]∥陈新.临床心律失常学.第2版.北京:人民卫生出版社,2009:333-348.
  • 2蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:142
  • 3胡大一.药物治疗心房颤动存在的一些问题[J].中华心血管病杂志,2006,34(4):291-292. 被引量:41
  • 4Atrial Fibrillation Follow-up Investigation of Rhythm Management(AFFIRM)Investigator:a comparison of rate control and rhythmcontrol in patients with atrial fibrillation[J].N Engl J Med,2002,347:1825-1833.
  • 5Van Gelder IC,Hagens VE,Bosker HA,et al.A comparison of ratecontrol and rhythm control in patients with recurrent persistent atri-al fibrillation[J].N Engl J Med,2002,347:1834-1840.

二级参考文献13

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
  • 2Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)Investigator:a comparison of rate control and rhythm control in patients with atrial fibrillation.N Engl J Med,2002,347:1825-1833.
  • 3van Gelder IC,Hagens VE,Bosker HA,et al.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.N Engl J Med,2002,347:1834-1840.
  • 4The Cardiac Arrhythmia Suppression Trial(CAST)Investigators.Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med,1989,321:406-412.
  • 5Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Europ Heart J,2001,22:1852-1923.
  • 6Khan IA. Pharmacological cardioversion of recent onset atrial fibrillation . Europ Heart J ,2004,25:1274-1276.
  • 7Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
  • 8Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA Guidlines for the management of patients with ST-Elevation myocardial infarction-Executive Summary. Circulation,2004,110:588-636.
  • 9Hammill SC. Cardiac arrhythmias. J Am Coll Cardiol, 2004, 44 (Suppl Ⅱ): 16A-17A.
  • 10Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med,2000,160:1741-1748.

共引文献181

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部